Gets 16 FDA nods, launches 11 products.

The article profiles generic drug manufacturing company Lupin, one of the journal's top pharmaceutical companies in India. It states that the company gained 16 approvals from the U.S. Food and Drug Association (FDA) and released 11 products in 2012. It mentions that Lupin achieved 24 percent growth in its international business which comprised 67 percent of its overall business. Moreover, Lupin entered a strategic partnership with Eli Lilly & Co. to promote range of insulin products.